Careers  |  Sign In  |  Register

World’s First Malaria Vaccine Announced by GlaxoSmithKline

According to an article published by Reuters, British pharmaceutical company GlaxoSmithKline (GSK) has announced the world’s first malaria vaccine—a shot known as RTS,S.  After thirty years of development at GSK, the vaccine currently awaits regulatory approval from the European Medicines Agency and the World Health Organization. The company states that the cost of RTS,S will match the manufacture cost, with an added five percent margin intended for further research in tropical diseases including, but not limited to malaria. While the drug provides only modest protection according to some clinical trial results, in conjunction with bed nets and other malaria drugs, it should prove to be a significant advancement in management of the mosquito-borne disease.

Read the article published by Reuters.